What is Evommune 's payments of stock issuance costs?

Evommune (EVMN) reported payments of stock issuance costs of $1.05M in Q4 2025.

What does payments of stock issuance costs mean?

Represents the cash outflows incurred for professional fees, legal expenses, and underwriting costs directly associated with the issuance of equity securities. These costs are typically deducted from the proceeds of the offering and reflect the friction costs of raising capital. Monitoring this helps investors understand the efficiency of the company's capital-raising activities.

Evommune EVMN Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

STU

StubHub Holdings, Inc.STUB

$2.06M—

SoundHound AI, Inc.SOUN

$0-100%

KDK

Kodiak AI, Inc. Common StockKDK

$0-100%

Immunovant, Inc.IMVT

$126K-60.5%

Piedmont Office Realty TrustPDM

$106K-36.9%

ArriVent BioPharma, Inc.AVBP

$17K—

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's payments of stock issuance costs?: Evommune (EVMN) reported payments of stock issuance costs of $1.05M in Q4 2025.
What does payments of stock issuance costs mean?: Represents the cash outflows incurred for professional fees, legal expenses, and underwriting costs directly associated with the issuance of equity securities. These costs are typically deducted from the proceeds of the offering and reflect the friction costs of raising capital. Monitoring this helps investors understand the efficiency of the company's capital-raising activities.